Psychiatric Journals

Psychiatry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Carney RM et al. – Treatment of patients with CHD and major depression with sertraline and omega–3 fatty acids did not result in superior depression outcomes at 10 weeks, compared with sertraline and placebo. Whether higher doses of omega–3 or sertraline, a different ratio of EPA to DHA, longer treatment, or omega–3 monotherapy can improve depression in patients with CHD remains to be determined.

Today in Neuro/Psych Pharmacol...keeping you current

Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men
Journal of Clinical Endocrinology and Metabolism, 11/24/09

Antipsychotic Prescribing Practices Following Withdrawal of Concomitant Carbamazepine
Journal of Psychiatric Practice, 11/24/09

Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness
Schizophrenia Bulletin, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address